Credence Research

Global Study On Antibacterial Drugs Market Shares, Strategies And Forecasts Worldwide 2017 – 2025 – Credence Research

The latest market report published by Credence Research, Inc. “Global Antibacterial Drugs Market – Growth, Share, Opportunities, Pipeline Analysis, Competitive Analysis, and Forecast, 2016 – 2022,” the antibacterial drugs market was valued at USD 42,232.2 Mn in 2015, and is expected to reach USD 45,909.4 Mn by 2022, expanding at a CAGR of 1.15% from 2016 to 2022.

Market Insights

Antibacterial drugs are derived from bacteria or molds or are synthesized de novo. These drugs treat infectious diseases caused by gram positive, gram negative, aerobic and anaerobic bacteria that cannot be treated by any other method unlike other diseases. Antibacterial drugs have several mechanisms of action, including inhibiting cell wall synthesis, increasing cell membrane permeability, interfering with protein synthesis, nucleic acid metabolism, and other metabolic processes.

Browse the full report Antibacterial Drugs Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 at

The alarming antibacterial-resistance crisis has penetrated the awareness of clinicians, researchers, policymakers, governments and the public at large. The key factors assisting the growth of antibacterial drugs market are mounting prevalence of infectious diseases, government support, and increased research and development activities. However, evolving drug-resistant species, launch of generics, and upcoming patent expirations are anticipated to restrict the growth of the global market through 2022. Globally, the rise in geriatric population is also being considered as one of the key growth factors as it will indirectly increase the demand for various antibacterial drugs. The demand for antibacterial drugs will continue to rise mainly due to increased prevalence of resistant species that demand development of innovative molecules.

Pipeline Analysis

The phase III drugs included in the pipeline analysis are solithromycin (Cempra, Inc.), VivaGel/ SPL7013 (Starpharma Holdings Limited), surotomycin (Merck & Co.), MK-3415A (Merck & Co.) and others. According to market experts, these upcoming drugs assure to provide enhanced efficacy, shorter onset of action and fewer side effects as compared to the currently available antibacterial drugs. Thus, future commercialization of these drugs during the forecast period 2016 – 2022 is anticipated to have a reflective impact on the growth of the overall antibacterial drugs market.

Request Sample:

Key Market Movements:

  • Asia Pacific presently dominates the overall market and is also projected to experience the fastest growth throughout the forecast period
  • The rising incidence and prevalence of antibacterial drug resistance bacteria strains such as Methicillin-resistant Staphylococcus aureus (MRSA)
  • Stringent regulatory policies applied by FDA and other government agencies across the world is expected to reduce the risk of infection outbreak in hospitals
  • Novel and developed treatments in pipeline are expected to assist the overall market growth of antibacterial drugs market

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.


Name: Chris Smith

Designation: Global Sales Manager

Ph: 1-800-361-8290



Brisk Insights

Antibacterial Drugs Market Opportunities, Trends, Size And Market Share 2017 – 2022 – Brisk Insights`

According to a recently published report by Brisk Insight, the Global Antibacterial Drugs Market is expected to grow at the CAGR of 1.2% during 2017-2025. The global antibacterial drugs market is segmented on the basis of drug class and geography. The report on global antibacterial drugs market forecast 2017-2025 (by drug class and geography) provides a detailed overview and predictive analysis of the market.

Full report available Antibacterial Drugs market: Global Industry Size, Growth, Share and Forecast to 2025 report at

Market Insights

Antibacterials commonly known as antibiotics are commonly prescribed in modern medicine, with surge in bacterial infection. Bacterial infection is of major concern especially in cirrhosis patients since it is associated with mortality and morbidity. According to a study held by the WHO, cirrhotic patients associated urinary tract infection is mainly caused by the bacterial sepsis followed by spontaneous bacterial peritonitis (15 – 23%), respiratory tract infection (6 – 10%) and bacteremia (4-9%). High incidence of bacterial infections, vigorous research and development, rise in geriatric population, and high incidence of nosocomial infections are some of the factors leading to growth of antibacterial drugs market. This report on antibacterial drugs market includes various drugs used in market for treatment along with pipeline analysis of novel drugs coming up in future.

Request Sample:

Scope of the report

1. Global Antibacterial drugs Market, by Drugs Type, 2015–2025 ($ Million)

1.1. Overview
1.2. Aminoglycosides
1.3. B-Lactams
1.3.1. Penicillins
1.3.2. Carbapenems
1.3.3. Cephalosporins
1.4. Tetracyclines
1.5. Sulfonamides
1.6. Quinolones
1.7. Macrolides
1.8. Phenicols
1.9. Miscellaneous Anti-bacterial Drugs
1.10. Pipeline Analysis
1.10.1. Projected sales of Phase III Drugs estimated till 2022 (US$ Mn) Solithromycin Actoxumab/bezlotoxumab (MK-3415A) Cadazolid Carbavance (meropenem/RPX7009) Eravacycline Omadacycline (PTK-0796) Others
1.11. Tabular Representation of Phase II and I Drugs

2. Global Antibacterial drugs Market, by Geography, 2015-2025 ($ Million)

2.1. North America (U.S. & Canada)
2.2. Europe (U.K., Germany & Rest of Europe)
2.3. Asia Pacific (China, Japan, and Rest of APAC)
2.4. Latin America (Brazil, Mexico and Rest of LATAM)
2.5. Middle East and Africa (UAE, Saudi Arabia, South Africa)

3. Profiles

3.1. Pfizer Inc.
3.2. Novartis AG
3.3. Merck & Co.
3.4. Astra Zeneca plc
3.5. Johnson & Johnson Limited
3.6. Abbott Laboratories
3.7. Eli Lilly and Company
3.8. Sanofi SA
3.9. Bristol-Myers Squibb Company
3.10. Bayer AG
3.11. GlaxoSmithKline plc
3.12. Others

About Us :

Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.

Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.

Contact Us :
Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
United Kingdom
Phone : +448081890034 (UK)
Website :